These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 1268086)

  • 1. Evaluation of methods to eliminate analytical interference in multiple myeloma patients with spurious hyperphosphatemia.
    Tian X; Zhao L; Ma J; Lu J; Zhu TY; Liu Y; Sun HX
    Lab Med; 2023 Nov; 54(6):598-602. PubMed ID: 36942666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed Structure and Pathophysiological Roles of the IgA-Albumin Complex in Multiple Myeloma.
    Kawata Y; Hirano H; Takahashi R; Miyano Y; Kimura A; Sato N; Morita Y; Kimura H; Fujita K
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of atypical IgA paraprotein interference on multiple chemistry assays: How to deal with it.
    Sarkar R
    J Med Biochem; 2024 Jun; 43(4):480-486. PubMed ID: 39139164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic plasma exchange for hyperviscosity syndrome in IgA multiple myeloma.
    Yurtsever N; Binns TC; Hendrickson JE; Tormey CA; Lee ES
    Lab Med; 2024 Jul; ():. PubMed ID: 39038224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Secretory Multiple Myeloma Associated With High-Risk Phenotype and Complex Cytogenetics Including t(8;22).
    Jiwani RA; Liput JR; Abraham A; Alhamad K; Kapdi M; Mota R; Forte K; McGill JR; Acer JC; Nisarga P; Jaeger NR; Sadashiv S; Mewawalla P
    J Hematol; 2024 Jun; 13(3):94-98. PubMed ID: 38993738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraprotein Sample Exchange in Australia and New Zealand - 2018.
    Wijeratne N; Tate JR; Toit SD; Smith JD; Soepnel A; Choy KW; Martin H; Henry R; Glegg K; Byrnes E; Wienholt L; Mollee P
    Clin Biochem Rev; 2019 Feb; 40(1):43-54. PubMed ID: 30828119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients.
    Bosseboeuf A; Seillier C; Mennesson N; Allain-Maillet S; Fourny M; Tallet A; Piver E; Lehours P; Mégraud F; Berthelot L; Harb J; Bigot-Corbel E; Hermouet S
    Front Immunol; 2020; 11():854. PubMed ID: 32536913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA and temperature dependent IgG complex formation in a patient with Waldenström's hypergammaglobulinaemic purpura.
    Roberts-Thomson PJ; Kemp AS
    Clin Exp Immunol; 1980 Jan; 39(1):164-9. PubMed ID: 7389190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between serum viscosity and intravascular IgA polymer concentration in IgA myeloma.
    Chandy KG; Stockley RA; Leonard RC; Crockson RA; Burnett D; MacLennan IC
    Clin Exp Immunol; 1981 Dec; 46(3):653-61. PubMed ID: 7337982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting IgA related hyperviscosity.
    Alkner U; Hansson UB; Lindström FD
    Clin Exp Immunol; 1983 Mar; 51(3):617-23. PubMed ID: 6851249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular size heterogeneity of immunoglobulins in health and disease.
    Roberts-Thomson PJ; Shepherd K
    Clin Exp Immunol; 1990 Mar; 79(3):328-34. PubMed ID: 2317941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated tissue damage. Hyperviscosity and other complications of paraproteinaemia.
    Preston FE
    J Clin Pathol Suppl (R Coll Pathol); 1979; 13():85-9. PubMed ID: 391830
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isotypic characterization of IgA paraproteins: association with other clinical and analytic data].
    González González JB; García Delgado R; Cámara Sáez E; Ortiz Maslloréns F
    Rev Clin Esp; 1996 Aug; 196(8):529-35. PubMed ID: 8984539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric IgA paraprotein on agarose gel electrophoresis immunofixation identifies a unique subset of IgA myeloma patients.
    Lee AYS; Lin MW
    Clin Chim Acta; 2021 Jan; 512():112-116. PubMed ID: 33127346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclasses IgG1--IgG4 in 84 sera with IgG paraprotein.
    Tichý M; Hrncír Z; Mracek J
    Neoplasma; 1978; 25(1):107-10. PubMed ID: 634402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors affecting survival in multiple myeloma].
    Tornóczky J; Tóth A; Sziládi E; Hoffmann E; Liszátz M
    Orv Hetil; 1990 Aug; 131(31):1679-84. PubMed ID: 2205822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperviscosity in plasma cell dyscrasias.
    Kwaan HC
    Clin Hemorheol Microcirc; 2013; 55(1):75-83. PubMed ID: 23455837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between paraprotein polymerization and clinical features in IgA myeloma.
    Roberts-Thomson PJ; Mason DY; MacLennan IC
    Br J Haematol; 1976 May; 33(1):117-30. PubMed ID: 1268086
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.